NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

No, the company will likely have clear studies from credible data and sources probably from the trial and other sources to assert these things to the regulators. As an investor one can decide to take anything “seriously” or not, but it has no real substantial meaning. It’s just a phrase. But the reality is, they would not say these things if they were not backed up.

Further I believe they have been measuring some of these things discussed all along and have made reference to it all vaguely, over the years in different contexts and presentations. I believe Dr. Liau had even referred to the various antigens they have discovered off-handedly, in some of her presentations commenting, for instance, on CMV a number of times.

I expect this is all very well documented. It just was not necessary or relevant for the JAMA publication.

Most companies, big and small will have such data collected and yes, they are expected to be truthful with their regulators and that will be the same whether it is MRK or NWBO.